Related Experiment Video
Updated: Dec 19, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Breast Cancer Risk Assessment: A Step-Wise Approach for Primary Care Providers on the Front Lines of Shared Decision
Adelaide H McClintock1, Anna L Golob2, Mary B Laya1
1Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington; Women's Health Care Center, Seattle, Washington.
Clinicians should assess breast cancer risk to personalize screening. Utilizing accurate risk-prediction models ensures appropriate surveillance and prevention strategies for women, aligning with precision medicine goals.
Area of Science:
- Oncology
- Preventive Medicine
- Medical Informatics
Background:
- Current breast cancer screening guidelines emphasize risk assessment for shared decision-making.
- Precision medicine aims to tailor screening intensity based on individual risk, optimizing surveillance for high-risk individuals and reducing unnecessary procedures for lower-risk women.
- Risk assessment is crucial for refining screening schedules, identifying candidates for genetic counseling, and determining eligibility for risk-reducing medications.
Purpose of the Study:
- To provide a stepwise approach for clinicians to assess individual breast cancer risk.
- To describe the features, appropriate use, and performance characteristics of common breast cancer risk-prediction models.
- To aid primary care providers in making evidence-based screening and prevention recommendations tailored to a woman's specific risk profile.
Main Methods:
- Review and synthesis of available breast cancer risk-assessment models.
- Description of the strengths, weaknesses, and performance metrics of selected models.
- Development of a practical, stepwise approach for clinical risk assessment.
Main Results:
- Multiple breast cancer risk-assessment models exist, each with unique performance characteristics.
- Understanding model performance is essential for accurate risk stratification.
- A structured approach facilitates efficient and accurate risk assessment in clinical practice.
Conclusions:
- Accurate breast cancer risk assessment is fundamental for personalized screening and prevention.
- Clinicians need to be knowledgeable about various risk-prediction models to select the most appropriate one for each patient.
- Implementing a stepwise risk assessment approach supports evidence-based decision-making and optimizes patient care in breast cancer prevention and screening.
More Related Videos
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Related Concept Videos
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preventive Healthcare Services
Cancer Survival Analysis
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
Relative Risk